Cargando…
Real‐world Israeli single institution experience with PET‐PSMA for staging of patients with clinically staged localized prostate carcinoma
BACKGROUND: A recent prospective trial, the proPSMA study, showed superior specificity and sensitivity of Positron emission tomography (PET) ‐ Prostate‐specific membrane antigen (PSMA) imaging compared standard Computerized tomography (CT) and bone scan for staging of recently diagnosed high‐risk lo...
Autores principales: | Zarbiv, Yonaton, Peerless, Yehudit, Wygoda, Marc, Orevi, Marina, Meir, Karen, Gofrit, Ofer N., Yutkin, Vladimir, Frank, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551983/ https://www.ncbi.nlm.nih.gov/pubmed/33934567 http://dx.doi.org/10.1002/cnr2.1386 |
Ejemplares similares
-
False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
por: Orevi, Marina, et al.
Publicado: (2022) -
(18)
F-FDG PET/CT Imaging of Boari Flap Mimicking Urothelial Cancer Recurrence
por: Fishberg, Sharon E., et al.
Publicado: (2022) -
Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates
por: Molineros, Gabriel, et al.
Publicado: (2021) -
PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023) -
Trimodal therapy in T2‐4aN0M0 bladder cancer––How to select the best candidate?
por: Gofrit, Ofer N., et al.
Publicado: (2020)